FDA withdraws emergency use authorization of COVID drug because it is unlikely to be effective against new variants
(WASHINGTON) -- The U.S. Food and Drug Administration said Thursday it is withdrawing its emergency use authorization of a COVID-19 antibody therapy as a prevention tool because it is unlikely to be effective against variants that are currently circulating.
Evusheld, which is made by British-Swedish... Read More.
